Cargando…

Biomarker Research in Parkinson’s Disease Using Metabolite Profiling

Biomarker research in Parkinson’s disease (PD) has long been dominated by measuring dopamine metabolites or alpha-synuclein in cerebrospinal fluid. However, these markers do not allow early detection, precise prognosis or monitoring of disease progression. Moreover, PD is now considered a multifacto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Havelund, Jesper F., Heegaard, Niels H. H., Færgeman, Nils J. K., Gramsbergen, Jan Bert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618327/ https://www.ncbi.nlm.nih.gov/pubmed/28800113 http://dx.doi.org/10.3390/metabo7030042

Ejemplares similares

Ethyl Pyruvate Increases Post-Ischemic Levels of Mitochondrial Energy Metabolites: A (13)C-Labeled Cerebral Microdialysis Study
por: Nygaard, Kevin H., et al.
Publicado: (2020)

In Vivo Microdialysis of Endogenous and (13)C-labeled TCA Metabolites in Rat Brain: Reversible and Persistent Effects of Mitochondrial Inhibition and Transient Cerebral Ischemia
por: Havelund, Jesper F., et al.
Publicado: (2019)

Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy
por: Bandres-Meriz, Julia, et al.
Publicado: (2023)

HLH‐30‐dependent rewiring of metabolism during starvation in C. elegans
por: Dall, Kathrine B., et al.
Publicado: (2021)

Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics
por: Nielsen, Jonas Ellegaard, et al.
Publicado: (2021)

Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains
por: Smalakyte, Dalia, et al.
Publicado: (2020)

Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
por: Okarmus, Justyna, et al.
Publicado: (2021)

High‐fat diet‐induced obesity augments the deleterious effects of estrogen deficiency on bone: Evidence from ovariectomized mice
por: Ali, Dalia, et al.
Publicado: (2022)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Premotor biomarkers for Parkinson's disease - a promising direction of research
por: Haas, Brian R, et al.
Publicado: (2012)

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features
por: Griffiths, William J., et al.
Publicado: (2021)

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
por: Stoessel, Daniel, et al.
Publicado: (2018)

Screening for Bioactive Metabolites in Plant Extracts Modulating Glucose Uptake and Fat Accumulation
por: El-Houri, Rime B., et al.
Publicado: (2014)

A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
por: Klatt, Stephan, et al.
Publicado: (2021)

Sphingolipids: membrane microdomains in brain development, function and neurological diseases
por: Olsen, Anne S. B., et al.
Publicado: (2017)

Plasma Metabolite Markers of Parkinson’s Disease and Atypical Parkinsonism
por: Pathan, Meerakhan, et al.
Publicado: (2021)

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022)

Profiling Analysis of Tryptophan Metabolites in the Urine of Patients with Parkinson’s Disease Using LC–MS/MS
por: Chung, So Hyeon, et al.
Publicado: (2023)

Comprehensive and quantitative profiling of lipid species in human milk, cow milk and a phospholipid-enriched milk formula by GC and MS/MS(ALL)
por: Sokol, Elena, et al.
Publicado: (2015)

Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle
por: Hingst, Janne R., et al.
Publicado: (2018)

Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
por: Taguchi, Y-h., et al.
Publicado: (2018)

Duplication in the Microtubule-Actin Cross-linking Factor 1 gene causes a novel neuromuscular condition
por: Jørgensen, Louise H., et al.
Publicado: (2014)

Biochemistry, proteomics, and phosphoproteomics of plant mitochondria from non-photosynthetic cells
por: Havelund, Jesper F., et al.
Publicado: (2013)

Recent developments in biomarkers in Parkinson disease
por: Schapira, Anthony H.V.
Publicado: (2013)

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer’s disease and mild cognitive impairment
por: Poulsen, Keld, et al.
Publicado: (2014)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

NAMPT-dependent NAD(+) biosynthesis controls circadian metabolism in a tissue-specific manner
por: Basse, Astrid L., et al.
Publicado: (2023)

Quantitative proteomics by amino acid labeling identifies novel NHR-49 regulated proteins in C. elegans
por: Fredens, Julius, et al.
Publicado: (2012)

Parkinson’s disease and translational research
por: Dinter, Elisabeth, et al.
Publicado: (2020)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson’s disease
por: Chan, Lung, et al.
Publicado: (2023)

Strength in numbers: “Omics” studies of C. elegans innate immunity
por: Simonsen, Karina T., et al.
Publicado: (2012)

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
por: Meles, Sanne K., et al.
Publicado: (2021)

Carbon Monoxide Releasing Molecule-A1 (CORM-A1) Improves Neurogenesis: Increase of Neuronal Differentiation Yield by Preventing Cell Death
por: Almeida, Ana S., et al.
Publicado: (2016)

Metabolic regulation of lifespan from a C. elegans perspective
por: Dall, Kathrine B., et al.
Publicado: (2019)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Gene Expression Profiling Combined with Bioinformatics Analysis Identify Biomarkers for Parkinson Disease
por: Diao, Hongyu, et al.
Publicado: (2012)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Identification of gut metabolites associated with Parkinson’s disease using bioinformatic analyses
por: Yan, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9s14bus59n8niipdbsh042qfc